Harvard Bioscience (HBIO) Net Income (2010 - 2026)

Harvard Bioscience (HBIO) has 16 years of Net Income data on file, last reported at -$3.4 million in Q1 2026.

• Net Income for Q1 2026 came in at -$3.4 million, up 93.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.3 million (up 82.16% YoY), and the FY2025 annual result was -$57.3 million, down 361.53% from the prior year.
• Net Income declined to -$3.4 million in Q1 2026 per HBIO's latest filing, from -$3.4 million in the prior quarter.
• Over five years, Net Income peaked at $2.4 million in Q2 2022 and troughed at -$50.3 million in Q1 2025.
• A 5-year average of -$5.1 million and a median of -$2.3 million in 2025 frame the typical range for Net Income.
• The sharpest annual moves came in 2022 and 2025: Net Income jumped 660.42% in 2022, then slumped 18988.89% in 2025.
• A 5-year view of Net Income shows it stood at -$2.2 million in 2022, then gained by 26.52% to -$1.6 million in 2023, then soared by 101.13% to $18000.0 in 2024, then tumbled by 18988.89% to -$3.4 million in 2025, then retreated by 0.71% to -$3.4 million in 2026.
• Business Quant data shows HBIO's Net Income at -$3.4 million in Q1 2026, -$3.4 million in Q4 2025, and -$1.2 million in Q3 2025.